Bayesian Capital Management, LP Ptc Therapeutics, Inc. Transaction History

Bayesian Capital Management, LP

  • $838 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$25.6 - $45.23 $273,920 - $483,960
-10,700 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$33.33 - $44.6 $356,631 - $477,220
10,700 New
10,700 $399,000
Q2 2018

Aug 14, 2018
SELL
$25.7 - $47.88 $335,487 - $625,025
-13,054 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$17.46 - $32.59 $227,922 - $425,429
13,054 New
13,054 $353,000

Others Institutions Holding PTCT

# of Institutions
228
Shares Held
78.1M
Call Options Held
144K
Put Options Held
54.8K
View Full List

About PTC THERAPEUTICS, INC.

PTCT Quotes by TradingView
  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.53B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email